Merck Sharp & Dohme B.V. (primary and secondary packaging, quality control, testing at release, batch release authorization)
UkraineAll drugs from this manufacturer
-
The drug is intended for adults with type 2 diabetes mellitus to improve blood sugar control. It is used as an adjunct to diet and physical exercise when metformin monotherapy does not provide sufficient results, or in combination with other drugs (insulin, sulfonylurea, etc.).
Dosage form: tablets, film-coated
Active substance Dosage sitagliptin 50 mg metformin 500 mg ATC: A10BD07
-
The drug is intended for adults with type 2 diabetes to improve blood sugar control. It is used as an adjunct to diet and exercise when other agents (e.g., metformin alone) are insufficient, or in combination with insulin or other antidiabetic medications.
Dosage form: tablets, film-coated
Active substance Dosage sitagliptin 50 mg metformin 850 mg ATC: A10BD07
-
The drug is intended for adults with type 2 diabetes mellitus to improve blood sugar control. It is used as an adjunct to diet and physical exercise when other agents (e.g., metformin alone) are insufficient, or in combination with insulin or other antidiabetic drugs.
Dosage form: tablets, film-coated
Active substance Dosage sitagliptin 50 mg metformin 1000 mg ATC: A10BD07